Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference, Webcast, Advisory

Twist Bioscience to Report Fiscal 2020 First Quarter Financial Results on Thursday, February 6, 2020


Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2020 first quarter ended December 31, 2019, following the close of market on Thursday, February 6, 2020. The company plans to hold a conference call and live audio webcast for analysts and investors at 4:30 p.m. Eastern Time to discuss its financial results and provide an update on the company's business. The press release with the financial results will be accessible from the company's website prior to the conference call through the Investor Relations section under the "Company" tab at www.twistbioscience.com.

The call can be accessed by dialing (866) 688-0947 (domestic) or (409) 217-8781 (international) and refer to the conference ID 9229258. A telephonic replay of the conference call will be available beginning approximately two hours after the call through February 13, 2020 and may be accessed by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international). The replay conference ID is 9229258. The webcast replay will be available for two weeks.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube


These press releases may also interest you

at 20:38
White Mountains Insurance Group, Ltd. announced today that MediaAlpha, Inc. ("MediaAlpha") priced an underwritten secondary public offering of 6,600,000 shares (not including 990,000 shares subject to the underwriters' option to purchase additional...

at 20:30
ICC Holdings, Inc. (the Company), parent company of Illinois Casualty Company, a regional, multi-line property and casualty insurance company focusing exclusively on the food and beverage industry, today reported unaudited results for the three...

at 20:25
Telefônica Brasil - , announces its results for 1Q24: 1Q24 Results: Telefônica Brasil S.A. Strong operating performance leading to above-inflation growth in revenues, EBITDA and net income R$ million  1Q24  1Q23 % Y-o-Y Net Operating Revenue 13,546...

at 20:20
Information Services Corporation ("ISC" or the "Company") today reported on the Company's financial results for the first quarter ended March 31, 2024. Capitalized terms that are used but not defined in this news release have the meaning ascribed...

at 20:10
Fresh off the revamped formula release of their patented creatine infused ready to drink recovery beverage, FITAID delivers a unique product drop strategy, putting customers in control of their permanent flavor collection. With the record...

at 20:00
Mashreq, a leading financial institution in the MENA region, today announced that it has selected Silent Eight to...



News published on and distributed by: